Header Logo

Elizabeth A Evans PhD

TitleProfessor
InstitutionUMass Chan – Baystate Regional Campus
DepartmentHealthcare Delivery and Population Sciences at UMass Chan - Baystate
AddressUniversity of Massachusetts Amherst
312 Arnold House, 715 North Pleasant St
Amherst MA 01003
Phone413-545-4434
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San Diego, San Diego, CA, United StatesBA
    Indiana University Bloomington, Bloomington, IN, United StatesMA
    University of California, Los Angeles, Los Angeles, CA, United StatesDOCA

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Evans E, Geissler KH. Use of Big Data and Ethical Issues for Populations with Substance Use Disorder. Value Health. 2023 Mar 13. PMID: 36921899.
      Citations:    Fields:    
    2. Friedmann PD, Dunn D, Michener P, Bernson D, Stopka TJ, Pivovarova E, Ferguson WJ, Rottapel R, Hoskinson R, Wilson D, Evans EA. COVID-19 impact on opioid overdose after jail release in Massachusetts. Drug Alcohol Depend Rep. 2023 Mar; 6:100141. PMID: 36879616.
      Citations:    
    3. Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J Natl Med Assoc. 2023 Feb 13. PMID: 36792456.
      Citations:    Fields:    
    4. Bailey A, Evans EA. Holyoke Early Access to Recovery and Treatment (HEART): A case study of a court-based intervention to reduce opioid overdose. J Ethn Subst Abuse. 2023 Jan 30; 1-23. PMID: 36715087.
      Citations:    Fields:    
    5. Bailey A, Harrington C, Evans EA. A scoping review of community-based post-opioid overdose intervention programs: implications of program structure and outcomes. Health Justice. 2023 Jan 28; 11(1):3. PMID: 36707446.
      Citations:    
    6. Harrington C, Bailey A, Delorme E, Hano S, Evans EA. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19. Subst Use Misuse. 2023; 58(2):266-274. PMID: 36510800.
      Citations:    Fields:    Translation:HumansPHPublic Health
    7. Matsumoto A, Santelices C, Evans EA, Pivovarova E, Stopka TJ, Ferguson WJ, Friedmann PD. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. Int J Drug Policy. 2022 11; 109:103823. PMID: 35994938.
      Citations: 1     Fields:    Translation:Humans
    8. Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Toro-Mejias LD, Friedmann PD, Evans EA. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. Int J Drug Policy. 2022 Dec; 110:103803. PMID: 35965159.
      Citations: 2     Fields:    Translation:Humans
    9. Fiddian-Green A, Gubrium A, Harrington C, Evans EA. Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder. Int J Environ Res Public Health. 2022 07 30; 19(15). PMID: 35954700.
      Citations:    Fields:    Translation:HumansPHPublic Health
    10. Evans EA. Commentary on Adams et al.: using administrative big data for the public good. Addiction. 2022 10; 117(10):2649-2650. PMID: 35818700.
      Citations:    Fields:    Translation:Humans
    11. Evans EA, Delorme E, Cyr KD, Geissler KH. The Massachusetts public health data warehouse and the opioid epidemic: A qualitative study of perceived strengths and limitations for advancing research. Prev Med Rep. 2022 Aug; 28:101847. PMID: 35669857.
      Citations:    
    12. Goodsmith N, Cohen AN, Pedersen ER, Evans E, Young AS, Hamilton AB. Predictors of Functioning and Recovery Among Men and Women Veterans with Schizophrenia. Community Ment Health J. 2023 01; 59(1):110-121. PMID: 35643881.
      Citations: 1     Fields:    Translation:Humans
    13. Pivovarova E, Evans EA, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug Alcohol Depend. 2022 05 01; 234:109394. PMID: 35349918.
      Citations: 1     Fields:    Translation:Humans
    14. Evans EA, Pivovarova E, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail. J Subst Abuse Treat. 2022 07; 138:108746. PMID: 35249789.
      Citations: 1     Fields:    Translation:Humans
    15. Evans EA, Wilson D, Friedmann PD. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug Alcohol Depend. 2022 02 01; 231:109254. PMID: 35063323.
      Citations: 6     Fields:    Translation:Humans
    16. Baker R, Evans E, Fielden A, Arnott B. Healthcare professionals' perspectives on infant feeding support in paediatric inpatients: single-centre qualitative study. BMJ Paediatr Open. 2021; 5(1):e001247. PMID: 34746446.
      Citations:    Fields:    Translation:Humans
    17. Geissler KH, Evans EA, Johnson JK, Whitehill JM. A Scoping Review of Data Sources for the Conduct of Policy-Relevant Substance Use Research. Public Health Rep. 2022 Sep-Oct; 137(5):944-954. PMID: 34543133.
      Citations: 1     Fields:    Translation:HumansAnimals
    18. Zhu Y, Mooney LJ, Yoo C, Evans EA, Kelleghan A, Saxon AJ, Curtis ME, Hser YI. Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone. Drug Alcohol Depend. 2021 11 01; 228:108996. PMID: 34555691.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    19. Hser YI, Zhu Y, Fei Z, Mooney LJ, Evans EA, Kelleghan A, Matthews A, Yoo C, Saxon AJ. Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial. Addiction. 2022 01; 117(1):151-161. PMID: 34105213.
      Citations: 2     Fields:    Translation:Humans
    20. Barnett A, Edwards K, Harper R, Evans E, Alexander D, Choudhary M, Richards G. The Association Between Autistic Traits and Disordered Eating is Moderated by Sex/Gender and Independent of Anxiety and Depression. J Autism Dev Disord. 2021 Jun; 51(6):1866-1879. PMID: 32852639.
      Citations: 6     Fields:    Translation:Humans
    21. Evans EA, Stopka TJ, Pivovarova E, Murphy SM, Taxman FS, Ferguson WJ, Bernson D, Santelices C, McCollister KE, Hoskinson R, Lincoln T, Friedmann PD. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN). J Subst Abuse Treat. 2021 09; 128:108275. PMID: 33483222.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    22. Donelan CJ, Hayes E, Potee RA, Schwartz L, Evans EA. COVID-19 and treating incarcerated populations for opioid use disorder. J Subst Abuse Treat. 2021 05; 124:108216. PMID: 33288348.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    23. Evans EA, Harrington C, Roose R, Lemere S, Buchanan D. Perceived Benefits and Harms of Involuntary Civil Commitment for Opioid Use Disorder. J Law Med Ethics. 2020 12; 48(4):718-734. PMID: 33404337.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    24. Evans EA, Goldwater E, Stanek EJ, Brierley-Bowers P, Buchanan D, Whitehill JM. Prevalence and Correlates of Cannabis Use in Massachusetts after Cannabis Legalization and before Retail Sales. J Psychoactive Drugs. 2021 Apr-Jun; 53(2):158-167. PMID: 33242292.
      Citations:    Fields:    Translation:HumansAnimals
    25. Evans EA, Delorme E, Cyr K, Goldstein DM. A qualitative study of big data and the opioid epidemic: recommendations for data governance. BMC Med Ethics. 2020 10 21; 21(1):101. PMID: 33087123.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    26. Montgomery L, Friedmann P, Abraham A, Evans E, Glass J, Ilgen M. Editorial: Health equity in substance use disorder treatment. J Subst Abuse Treat. 2020 11; 118:108101. PMID: 32807568.
      Citations:    Fields:    Translation:Humans
    27. Friedmann PD, Abraham A, Evans E, Glass J, Ilgen M, Montgomery L. Editorial: COVID-19 and its impact on SUD treatment. J Subst Abuse Treat. 2020 10; 117:108091. PMID: 32747147.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    28. Evans EA, Sayers SR, Kodji X, Xia Y, Shaikh M, Rizvi A, Frame J, Brain SD, Philpott MP, Hannen RF, Caton PW. Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome. Mol Metab. 2020 11; 41:101047. PMID: 32599074.
      Citations: 5     Fields:    Translation:HumansAnimals
    29. Geissler KH, Evans EA. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity. Med Care. 2020 02; 58(2):101-107. PMID: 31688556.
      Citations: 3     Fields:    Translation:Humans
    30. Evans EA, Goff SL, Upchurch DM, Grella CE. Childhood adversity and mental health comorbidity in men and women with opioid use disorders. Addict Behav. 2020 03; 102:106149. PMID: 31855783.
      Citations: 12     Fields:    Translation:Humans
    31. Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2?years: Results from a multisite randomized trial of adults with opioid use disorder. J Subst Abuse Treat. 2019 11; 106:19-28. PMID: 31540607.
      Citations: 10     Fields:    Translation:Humans
    32. Evans EA, Zhu Y, Yoo C, Huang D, Hser YI. Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder. Addiction. 2019 08; 114(8):1396-1404. PMID: 30916463.
      Citations: 12     Fields:    Translation:Humans
    33. Kodji X, Arkless KL, Kee Z, Cleary SJ, Aubdool AA, Evans E, Caton P, Pitchford SC, Brain SD. Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis. FASEB J. 2019 02; 33(2):1578-1594. PMID: 30204499.
      Citations: 15     Fields:    Translation:AnimalsCells
    34. Haines A, Perkins E, Evans EA, McCabe R. Multidisciplinary team functioning and decision making within forensic mental health. Ment Health Rev (Brighton). 2018; 23(3):185-196. PMID: 30464703.
      Citations:    
    35. Evans EA, Herman PM, Washington DL, Lorenz KA, Yuan A, Upchurch DM, Marshall N, Hamilton AB, Taylor SL. Gender Differences in Use of Complementary and Integrative Health by U.S. Military Veterans with Chronic Musculoskeletal Pain. Womens Health Issues. 2018 Sep - Oct; 28(5):379-386. PMID: 30174254.
      Citations: 11     Fields:    Translation:Humans
    36. Zhu Y, Evans EA, Mooney LJ, Saxon AJ, Kelleghan A, Yoo C, Hser YI. Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial. J Neuroimmune Pharmacol. 2018 12; 13(4):488-497. PMID: 30094695.
      Citations: 14     Fields:    Translation:Humans
    37. Evans EA, Glover DL, Washington DL, Hamilton AB. Psychosocial Factors that Shape Substance Abuse and Related Mental Health of Women Military Veterans who Use Community-Based Services. Subst Use Misuse. 2018 09 19; 53(11):1878-1892. PMID: 29485302.
      Citations: 3     Fields:    Translation:Humans
    38. Evans EA, Upchurch DM, Simpson T, Hamilton AB, Hoggatt KJ. Differences by Veteran/civilian status and gender in associations between childhood adversity and alcohol and drug use disorders. Soc Psychiatry Psychiatr Epidemiol. 2018 04; 53(4):421-435. PMID: 29188311.
      Citations: 8     Fields:    Translation:Humans
    39. Krebs E, Enns B, Evans E, Urada D, Anglin MD, Rawson RA, Hser YI, Nosyk B. Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California. Ann Intern Med. 2018 01 02; 168(1):10-19. PMID: 29159398.
      Citations: 22     Fields:    Translation:Humans
    40. Caton PW, Evans EA, Philpott MP, Hannen RF. Can the skin make you fat? A role for the skin in regulating adipose tissue function and whole-body glucose and lipid homeostasis. Curr Opin Pharmacol. 2017 12; 37:59-64. PMID: 28985599.
      Citations: 5     Fields:    Translation:HumansAnimals
    41. Wang L, Min JE, Krebs E, Evans E, Huang D, Liu L, Hser YI, Nosyk B. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. Int J Drug Policy. 2017 11; 49:32-40. PMID: 28888099.
      Citations: 37     Fields:    Translation:Humans
    42. Evans EA, Grella CE, Washington DL, Upchurch DM. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Drug Alcohol Depend. 2017 05 01; 174:128-136. PMID: 28324815.
      Citations: 34     Fields:    Translation:Humans
    43. Evans EA, Grella CE, Upchurch DM. Gender differences in the effects of childhood adversity on alcohol, drug, and polysubstance-related disorders. Soc Psychiatry Psychiatr Epidemiol. 2017 07; 52(7):901-912. PMID: 28258335.
      Citations: 13     Fields:    Translation:Humans
    44. Krebs E, Urada D, Evans E, Huang D, Hser YI, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction. 2017 May; 112(5):838-851. PMID: 27981691.
      Citations: 17     Fields:    Translation:Humans
    45. Krebs E, Min JE, Evans E, Li L, Liu L, Huang D, Urada D, Kerr T, Hser YI, Nosyk B. Estimating State Transitions for Opioid Use Disorders. Med Decis Making. 2017 07; 37(5):483-497. PMID: 28027027.
      Citations: 5     Fields:    Translation:Humans
    46. Metz VE, Sullivan MA, Jones JD, Evans E, Luba R, Vogelman J, Comer SD. Racial Differences in HIV and HCV Risk Behaviors, Transmission, and Prevention Knowledge among Non-Treatment-Seeking Individuals with Opioid Use Disorder. J Psychoactive Drugs. 2017 Jan-Mar; 49(1):59-68. PMID: 27918880.
      Citations: 6     Fields:    Translation:Humans
    47. Evans EA, Perkins E, Clarke P, Haines A, Baldwin A, Whittington R. Care home manager attitudes to balancing risk and autonomy for residents with dementia. Aging Ment Health. 2018 Feb; 22(2):261-269. PMID: 27768393.
      Citations: 3     Fields:    Translation:Humans
    48. van der Linde RM, Dening T, Stephan BC, Prina AM, Evans E, Brayne C. Longitudinal course of behavioural and psychological symptoms of dementia: systematic review. Br J Psychiatry. 2016 11; 209(5):366-377. PMID: 27491532.
      Citations: 64     Fields:    Translation:Humans
    49. Iacono T, Evans E, Davis A, Bhardwaj A, Turner B, Torr J, Trollor JN. Family caring of older adults with intellectual disability and coping according to loci of responsibility. Res Dev Disabil. 2016 Oct; 57:170-80. PMID: 27442688.
      Citations: 1     Fields:    Translation:Humans
    50. Hser YI, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, Woody G, Liu D, Wakim P, Matthews AG, Hatch-Maillette M, Jelstrom E, Wiest K, McLaughlin P, Ling W. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction. 2016 Apr; 111(4):695-705. PMID: 26599131.
      Citations: 78     Fields:    Translation:Humans
    51. Saroyan JM, Evans EA, Segoshi A, Vosburg SK, Miller-Saultz D, Sullivan MA. Interviewing and Urine Drug Toxicology Screening in a Pediatric Pain Management Center: An Analysis of Analgesic Nonadherence and Aberrant Behaviors in Adolescents and Young Adults. Clin J Pain. 2016 Jan; 32(1):1-6. PMID: 25756559.
      Citations: 3     Fields:    Translation:Humans
    52. Evans E, Padwa H, Li L, Lin V, Hser YI. Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment. J Subst Abuse Treat. 2015 Dec; 59:10-9. PMID: 26321439.
      Citations: 3     Fields:    Translation:Humans
    53. Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD, Wood E, Montaner JS. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs. Clin Infect Dis. 2015 Oct 01; 61(7):1157-65. PMID: 26113656.
      Citations: 29     Fields:    Translation:Humans
    54. Chitty KM, Evans E, Torr JJ, Iacono T, Brodaty H, Sachdev P, Trollor JN. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study. Aust N Z J Psychiatry. 2016 Apr; 50(4):352-62. PMID: 26019276.
      Citations: 6     Fields:    Translation:Humans
    55. Evans E, Li L, Min J, Huang D, Urada D, Liu L, Hser YI, Nosyk B. Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10. Addiction. 2015 Jun; 110(6):996-1005. PMID: 25644938.
      Citations: 48     Fields:    Translation:Humans
    56. Hser YI, Evans E, Grella C, Ling W, Anglin D. Long-term course of opioid addiction. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):76-89. PMID: 25747921.
      Citations: 90     Fields:    Translation:Humans
    57. Hser YI, Lanza HI, Li L, Kahn E, Evans E, Schulte M. Maternal mental health and children's internalizing and externalizing behaviors: Beyond maternal substance use disorders. J Child Fam Stud. 2015 Mar; 24(3):638-648. PMID: 25750503.
      Citations:    
    58. Evans E, Li L, Urada D, Anglin MD. Comparative Effectiveness of California's Proposition 36 and Drug Court Programs Before and After Propensity Score Matching. Crime Delinq. 2014 Sep; 60(6):909-938. PMID: 25342859.
      Citations:    
    59. Evans EA, Sullivan MA. Abuse and misuse of antidepressants. Subst Abuse Rehabil. 2014; 5:107-20. PMID: 25187753.
      Citations:    
    60. Hser YI, Evans E, Grella C. Commentary on Degenhardt et?al. (2014): Regional variation in the global burden of disease attributable to opioid dependence-where do the data come from and does population size matter? Addiction. 2014 Aug; 109(8):1334-5. PMID: 25041203.
      Citations: 2     Fields:    Translation:Humans
    61. Nosyk B, Li L, Evans E, Urada D, Huang D, Wood E, Rawson R, Hser YI. Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012. Drug Alcohol Depend. 2014 Oct 01; 143:149-57. PMID: 25110333.
      Citations: 14     Fields:    Translation:Humans
    62. Gill KE, Evans E, Kayser J, Ben-David S, Messinger J, Bruder G, Malaspina D, Corcoran CM. Smell identification in individuals at clinical high risk for schizophrenia. Psychiatry Res. 2014 Dec 15; 220(1-2):201-4. PMID: 25066961.
      Citations: 5     Fields:    Translation:Humans
    63. Evans E, Li L, Buoncristiani S, Hser YI. Perceived neighborhood safety, recovery capital, and successful outcomes among mothers 10 years after substance abuse treatment. Subst Use Misuse. 2014 Sep; 49(11):1491-503. PMID: 24832914.
      Citations: 6     Fields:    Translation:Humans
    64. Headley S, Germain M, Wood R, Joubert J, Milch C, Evans E, Poindexter A, Cornelius A, Brewer B, Pescatello LS, Parker B. Short-term aerobic exercise and vascular function in CKD stage 3: a randomized controlled trial. Am J Kidney Dis. 2014 Aug; 64(2):222-9. PMID: 24776325.
      Citations: 40     Fields:    Translation:Humans
    65. Evans E, Li L, Pierce J, Hser YI. Explaining long-term outcomes among drug dependent mothers treated in women-only versus mixed-gender programs. J Subst Abuse Treat. 2013 Sep; 45(3):293-301. PMID: 23702103.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    66. Anglin MD, Nosyk B, Jaffe A, Urada D, Evans E. Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36. Am J Public Health. 2013 Jun; 103(6):1096-102. PMID: 23597352.
      Citations: 13     Fields:    Translation:Humans
    67. Evans E, Li L, Grella C, Brecht ML, Hser YI. Developmental timing of first drug treatment and 10-year patterns of drug use. J Subst Abuse Treat. 2013 Mar; 44(3):271-9. PMID: 22959075.
      Citations: 8     Fields:    Translation:Humans
    68. Nosyk B, Sun H, Evans E, Marsh DC, Anglin MD, Hser YI, Anis AH. Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction. 2012 Sep; 107(9):1621-9. PMID: 22385013.
      Citations: 24     Fields:    Translation:Humans
    69. Eby LT, Sparks TE, Evans E, Selzer JA. A qualitative examination of the positive and negative consequences associated with going tobacco-free in substance abuse treatment: the NY State experience. Nicotine Tob Res. 2012 Dec; 14(12):1407-17. PMID: 22416113.
      Citations: 11     Fields:    Translation:Humans
    70. Hser YI, Hunt SA, Evans E, Chang YJ, Messina NP. Hispanic parenting women in women-only versus mixed-gender drug treatment: a 10-year prospective study. Addict Behav. 2012 Jun; 37(6):729-35. PMID: 22398357.
      Citations: 1     Fields:    Translation:Humans
    71. Evans E, Pierce J, Li L, Rawson R, Hser YI. More alike than different: health needs, services utilization, and outcomes of Asian American and Pacific Islander (AAPI) populations treated for substance use disorders. J Ethn Subst Abuse. 2012; 11(4):318-38. PMID: 23216439.
      Citations: 3     Fields:    Translation:Humans
    72. Hser YI, Kagihara J, Huang D, Evans E, Messina N. Mortality among substance-using mothers in California: a 10-year prospective study. Addiction. 2012 Jan; 107(1):215-22. PMID: 21831178.
      Citations: 20     Fields:    Translation:Humans
    73. Evans E, Huang D, Hser YI. High-risk offenders participating in court-supervised substance abuse treatment: characteristics, treatment received, and factors associated with recidivism. J Behav Health Serv Res. 2011 Oct; 38(4):510-25. PMID: 21479770.
      Citations: 5     Fields:    Translation:Humans
    74. Huang DY, Evans E, Hara M, Weiss RE, Hser YI. Employment Trajectories: Exploring Gender Differences and Impacts of Drug Use. J Vocat Behav. 2011 Aug; 79(1):277-289. PMID: 21765533.
      Citations:    
    75. Hser YI, Li J, Jiang H, Zhang R, Du J, Zhang C, Zhang B, Evans E, Wu F, Chang YJ, Peng C, Huang D, Stitzer ML, Roll J, Zhao M. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction. 2011 Oct; 106(10):1801-9. PMID: 21793958.
      Citations: 36     Fields:    Translation:Humans
    76. Hser YI, Evans E, Huang D, Messina N. Long-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs. J Subst Abuse Treat. 2011 Sep; 41(2):115-23. PMID: 21466942.
      Citations: 19     Fields:    Translation:Humans
    77. Li L, Evans E, Hser YI. A Marginal Structural Modeling Approach to Assess the Cumulative Effect of Drug Treatment on the Later Drug Use Abstinence. J Drug Issues. 2010 Dec; 40(1):221-240. PMID: 21566677.
      Citations:    
    78. Prendergast M, Huang D, Evans E, Hser YI. Are There Gender Differences in Arrest Trajectories among Adult Drug Abuse Treatment Participants? J Drug Issues. 2010 Dec; 40(1):7-26. PMID: 21052519.
      Citations:    
    79. Evans E, Anglin MD, Urada D, Yang J. Promising practices for delivery of court-supervised substance abuse treatment: perspectives from six high-performing California counties operating Proposition 36. Eval Program Plann. 2011 May; 34(2):124-34. PMID: 20965568.
      Citations: 4     Fields:    Translation:Humans
    80. Evans E, Hser YI, Huang D. Employment services utilization and outcomes among substance abusing offenders participating in California's proposition 36 drug treatment initiative. J Behav Health Serv Res. 2010 Oct; 37(4):461-76. PMID: 19688598.
      Citations: 4     Fields:    Translation:Humans
    81. Evans E, Li L, Hser YI. Client and program factors associated with dropout from court mandated drug treatment. Eval Program Plann. 2009 Aug; 32(3):204-12. PMID: 19150133.
      Citations: 21     Fields:    Translation:Humans
    82. Evans E, Murphy DA, Grella CE, Mouttapa M, Hser YI. Regulatory Issues Encountered when Conducting Longitudinal Substance Abuse Research. J Drug Issues. 2008 Oct 01; 38(4):1003-1026. PMID: 20379383.
      Citations:    
    83. Hser YI, Evans E, Huang D, Brecht ML, Li L. Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. Addict Behav. 2008 Dec; 33(12):1581-9. PMID: 18790574.
      Citations: 36     Fields:    Translation:HumansPHPublic Health
    84. Evans E, Grella CE, Murphy DA, Hser YI. Using administrative data for longitudinal substance abuse research. J Behav Health Serv Res. 2010 Apr; 37(2):252-71. PMID: 18679805.
      Citations: 29     Fields:    Translation:Humans
    85. Evans E, Li L, Hser YI. Treatment entry barriers among California's Proposition 36 offenders. J Subst Abuse Treat. 2008 Dec; 35(4):410-8. PMID: 18514474.
      Citations: 11     Fields:    Translation:Humans
    86. Brecht ML, Huang D, Evans E, Hser YI. Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users. Drug Alcohol Depend. 2008 Aug 01; 96(3):193-201. PMID: 18329825.
      Citations: 55     Fields:    Translation:Humans
    87. Hser YI, Evans E. Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project. Eval Program Plann. 2008 May; 31(2):125-35. PMID: 18374980.
      Citations: 27     Fields:    Translation:Humans
    88. Murphy DA, Brecht ML, Herbeck D, Evans E, Huang D, Hser YI. Longitudinal HIV risk behavior among the Drug Abuse Treatment Outcome Studies (DATOS) adult sample. Eval Rev. 2008 Feb; 32(1):83-112. PMID: 18198171.
      Citations: 6     Fields:    Translation:Humans
    89. Brecht ML, Stein J, Evans E, Murphy DA, Longshore D. Predictors of intention to change HIV sexual and injection risk behaviors among heterosexual methamphetamine-using offenders in drug treatment: a test of the AIDS Risk Reduction Model. J Behav Health Serv Res. 2009 Apr; 36(2):247-66. PMID: 18214688.
      Citations: 6     Fields:    Translation:Humans
    90. Hser YI, Huang D, Brecht ML, Li L, Evans E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. J Addict Dis. 2008; 27(3):13-21. PMID: 18956525.
      Citations: 47     Fields:    Translation:Humans
    91. Fosados R, Evans E, Hser YI. Ethnic differences in utilization of drug treatment services and outcomes among Proposition 36 offenders in California. J Subst Abuse Treat. 2007 Dec; 33(4):391-9. PMID: 17499958.
      Citations: 13     Fields:    Translation:Humans
    92. Hser YI, Evans E, Teruya C, Huang D, Anglin MD. Predictors of short-term treatment outcomes among California's Proposition 36 participants. Eval Program Plann. 2007 May; 30(2):187-96. PMID: 17689324.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    93. Hser YI, Teruya C, Brown AH, Huang D, Evans E, Anglin MD. Impact of California's Proposition 36 on the drug treatment system: treatment capacity and displacement. Am J Public Health. 2007 Jan; 97(1):104-9. PMID: 17138930.
      Citations: 16     Fields:    Translation:Humans
    94. Evans E, Longshore D, Prendergast M, Urada D. Evaluation of the Substance Abuse and Crime Prevention Act: client characteristics, treatment completion and re-offending three years after implementation. J Psychoactive Drugs. 2006 Nov; Suppl 3:357-67. PMID: 17357527.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    95. Evans E, Spear SE, Huang YC, Hser YI. Outcomes of drug and alcohol treatment programs among American Indians in California. Am J Public Health. 2006 May; 96(5):889-96. PMID: 16571710.
      Citations: 21     Fields:    Translation:Humans
    96. Teruya C, Hardy M, Hser YI, Evans E. Implementation of a statewide outcome monitoring system: lessons learned from substance abuse treatment provider staff. Qual Health Res. 2006 Mar; 16(3):337-52. PMID: 16449685.
      Citations: 2     Fields:    Translation:Humans
    97. Ettner SL, Huang D, Evans E, Ash DR, Hardy M, Jourabchi M, Hser YI. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"? Health Serv Res. 2006 Feb; 41(1):192-213. PMID: 16430607.
      Citations: 61     Fields:    Translation:Humans
    98. Hser YI, Grella C, Evans E, Huang YC. Utilization and outcomes of mental health services among patients in drug treatment. J Addict Dis. 2006; 25(1):73-85. PMID: 16597575.
      Citations: 5     Fields:    Translation:Humans
    99. Hser YI, Evans E, Huang YC. Treatment outcomes among women and men methamphetamine abusers in California. J Subst Abuse Treat. 2005 Jan; 28(1):77-85. PMID: 15723735.
      Citations: 62     Fields:    Translation:Humans
    100. Hser YI, Evans E, Huang D, Anglin DM. Relationship between drug treatment services, retention, and outcomes. Psychiatr Serv. 2004 Jul; 55(7):767-74. PMID: 15232015.
      Citations: 84     Fields:    Translation:Humans
    101. Evans E, Hser YI. Pilot-testing a statewide outcome monitoring system: overview of the California Treatment Outcome Project (CALTOP). J Psychoactive Drugs. 2004 May; Suppl 2:109-14. PMID: 15279122.
      Citations: 16     Fields:    Translation:Humans
    102. Evans E, Longshore D. Evaluation of the substance abuse and crime prevention act: treatment clients and program types during the first year of implementation. J Psychoactive Drugs. 2004 May; Suppl 2:165-74. PMID: 15279129.
      Citations: 8     Fields:    Translation:Humans
    103. Evans EA, Jeste DV. William Carlos Williams. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):129-33; discussion 128. PMID: 15010341.
      Citations:    Fields:    Translation:Humans
    104. Hser YI, Teruya C, Evans EA, Longshore D, Grella C, Farabee D. Treating drug-abusing offenders. Initial findings from a five-county study on the impact of California's Proposition 36 on the treatment system and patient outcomes. Eval Rev. 2003 Oct; 27(5):479-505. PMID: 14531316.
      Citations: 26     Fields:    Translation:Humans
    Evans's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (270)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _